CMX-2043 is a novel analogue of Induced arrthmia and mortality of rats with reducing the ratio of myocardial infarct to area at risk.
[1]. Alan S Lader, et al. CMX-2043 Mechanisms of Action In Vitro. J Cardiovasc Pharmacol. 2016 Sept;68:241-247.
[2]. Baguisi A, et al. CMX-2043 Efficacy in a Rat Model of Cardiac Ischemia-Reperfusion Injury. J Cardiovasc Pharmacol Ther. 2016 Nov;21(6):563-569.
















